Vanlent Anne is a director of Trevi Therapeutics Inc.
Person profile
Roles
Address
Princeton, New Jersey
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Trevi Therapeutics, Inc.
30 Jun 23
3
ObsEva SA
3 Jan 23
4
APPLIED GENETIC TECHNOLOGIES CORP
1 Dec 22
4/A
Trevi Therapeutics, Inc.
1 Jul 22
4
Trevi Therapeutics, Inc.
23 Jun 22
4
APPLIED GENETIC TECHNOLOGIES CORP
2 Dec 21
4
Trevi Therapeutics, Inc.
17 Jun 21
4
APPLIED GENETIC TECHNOLOGIES CORP
18 Dec 20
4
Trevi Therapeutics, Inc.
15 Jun 20
4
APPLIED GENETIC TECHNOLOGIES CORP
6 Dec 19
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
28 Jun 23 | TRVI Trevi Therapeutics | Nonstatutory Stock Option Common Stock | Grant | Acquire A | No | No | 2.27 | 30,000 | 68.10 k | 30,000 |
30 Nov 22 | AGTC Applied Genetic Technologies | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 2.17 | 14,000 | 30.38 k | 0 |
30 Nov 22 | AGTC Applied Genetic Technologies | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 4.72 | 12,000 | 56.64 k | 0 |
30 Nov 22 | AGTC Applied Genetic Technologies | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 3.02 | 10,000 | 30.20 k | 0 |
30 Nov 22 | AGTC Applied Genetic Technologies | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 6.9 | 10,000 | 69.00 k | 0 |
30 Nov 22 | AGTC Applied Genetic Technologies | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 4.25 | 10,000 | 42.50 k | 0 |
30 Nov 22 | AGTC Applied Genetic Technologies | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 7.75 | 8,000 | 62.00 k | 0 |
30 Nov 22 | AGTC Applied Genetic Technologies | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 15.13 | 16,000 | 242.08 k | 0 |